Generated by AI
Artivion Inc. is a medical device company focused on cardiac and vascular surgery, with a particular emphasis on the treatment of aortic disease. Artivion develops, manufactures, processes, and distributes a broad portfolio of products used in complex surgical procedures, including aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable human tissues for cardiac and vascular applications. Its offerings support surgeons in open, hybrid, and minimally invasive procedures, making the company a specialized supplier in advanced cardiovascular care. Artivion also provides tissue preservation services, extending its role beyond devices into biologic solutions used in transplant and reconstructive settings. With products sold across global markets, Artivion occupies an important niche in the medical technology sector centered on aortic repair and cardiovascular surgery.
Website1655 Roberts Boulevard NW
Kennesaw, GA, 30144
United States
The latest articles about AORT.
Artivion has seen its share price fall sharply over the past year, even as the business reports higher revenue and prepares new products for market. With the stock now trading around US$20.64, the key question is whether that price still lines up with what the company is generating in sales. The share price has declined 54.1% over the past year, which puts the focus squarely on whether the current market value is still in step with Artivion's revenue base. Recent double digit revenue growth,...
Summary of Aug 8's posts. Generated by AI.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about AORT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.